文献速递消化道肿瘤与早癌消化内镜

全球结直肠癌诊断时分期分布:一项证据合成

Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-12-16

36国主要分析显示远处转移比例中位数23.7%(四分位距21.8%-26.3%),范围从波多黎各16.2%至阿曼和拉脱维亚28.2%;年轻患者、结肠癌及未实施筛查者转移比例更高;人类发展指数与远处转移比例呈负相关(ρ=-0.48)。

要点

  • 36国主要分析中,结直肠癌远处转移比例中位数23.7%(IQR 21.8%-26.3%),范围16.2%-28.2%。
  • 年轻患者、结肠癌患者及未实施筛查者远处转移比例更高,男女间无明显差异。
  • 人类发展指数(ρ=-0.48)和社会人口指数(ρ=-0.26)较高与远处转移比例较低相关。

核心结论

  • 全球结直肠癌分期分布存在差异,提示需要针对性干预以加强早期发现和管理,尤其是在高转移地区。

研究设计与样本

  • 系统检索MEDLINE和Embase自建库至2023年12月6日,并通过已发表癌症报告检索灰色文献。
  • 纳入报告确诊结直肠癌分期分布的基于人群或医院癌症登记研究。
  • 提取基于TNM、监测流行病学和最终结果(SEER)或Dukes分期系统的分期特异性比例。
  • 按性别、年龄、肿瘤部位、日历时期和人群筛查实施状态进行亚组分析。

主要发现

  • 36个主要分析国家中,最近期远处转移性结直肠癌比例从波多黎各16.2%至阿曼和拉脱维亚28.2%,中位数23.7%(四分位距21.8%-26.3%)。
  • 年轻患者、结肠癌患者及未实施筛查者远处转移比例更高,男女间无明显差异。
  • 部分国家/地区远处转移性结直肠癌比例随时间下降,如南葡萄牙从2000年36.5%降至2016年22.2%;其他国家保持稳定(如奥地利、比利时)或上升(如美国、斯洛文尼亚、西班牙)。
  • 较高人类发展指数(HDI)和社会人口指数(SDI)与较低远处转移性结直肠癌比例相关(HDI:ρ=-0.48;SDI:ρ=-0.26)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Stage at diagnosis is a key prognostic factor for colorectal cancer (CRC) survival. We aimed to assess the global distribution of CRC staging at diagnosis using population-based or hospital-based registry data. METHODS: We systematically searched in MEDLINE and Embase from their inception until December 6, 2023. Gray literature was searched through published cancer reports. Studies from population-based or hospital-based cancer registries reporting the stage distribution of diagnosed CRC were included. We extracted stage-specific proportions among patients with CRC based on TNM; Surveillance, Epidemiology, and End Results; or Dukes staging systems. Subgroup analyses by sex, age, tumor site, calendar period, and status of population-based screening were performed. Correlations between the Human Development Index (HDI), Socio-Demographic Index (SDI), and the distant metastatic CRC proportion were also evaluated. RESULTS: A total of 84 eligible studies/reports from 46 countries were analyzed, covering 3.8 million patients. Among 36 countries included in the main analysis, the most recent distant metastatic CRC proportions varied from 16.2% in Puerto Rico to 28.2% in Oman and Latvia, with a median of 23.7% (interquartile range, 21.8%-26.3%). Higher metastatic proportions were observed in younger patients, those with colon cancer, and those without screening implementation, with no apparent difference between males and females. Over time, some countries/regions, such as Southern Portugal (36.5% in 2000 to 22.2% in 2016), showed declining proportions of metastatic CRC, whereas others remained stable (eg, Austria, Belgium) or increased (eg, United States, Slovenia, Spain). Higher HDI and SDI were correlated with lower proportions of distant metastatic CRC (HDI: ρ = -0.48; SDI: ρ = -0.26). CONCLUSIONS: Global disparities in CRC staging exist, indicating a need for targeted interventions to enhance early detection and management, especially in high-metastasis areas.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Guo L, Wang L, Cai L, et al. Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis. Clin Gastroenterol Hepatol. 2024. PMID: 39694204. doi:10.1016/j.cgh.2024.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。